Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 213,000 | 168,000 | 130,000 | 57,000 | -156,000 |
| Depreciation Amortization | 22,000 | 18,000 | 12,000 | 5,000 | 26,000 |
| Accounts receivable | -25,000 | 3,000 | 9,000 | 13,000 | 15,000 |
| Accounts payable and accrued liabilities | 201,000 | 30,000 | 6,000 | 7,000 | -103,000 |
| Other Working Capital | 173,000 | 30,000 | 19,000 | 34,000 | -19,000 |
| Other Operating Activity | -231,000 | -63,000 | -16,000 | -27,000 | 44,000 |
| Operating Cash Flow | $353,000 | $186,000 | $160,000 | $89,000 | $-193,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,000 | -2,000 | -1,000 | N/A | -4,000 |
| Purchase Sale Intangibles | -10,000 | -10,000 | -29,000 | 1,000 | N/A |
| Other Investing Activity | -10,000 | -10,000 | -29,000 | 1,000 | 0 |
| Investing Cash Flow | $-14,000 | $-12,000 | $-30,000 | $1,000 | $-4,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250,000 | 250,000 | 250,000 | N/A | N/A |
| Debt Repayment | -236,000 | -236,000 | -235,000 | -1,000 | -4,000 |
| Common Stock Issued | 1,000 | N/A | N/A | N/A | 1,000 |
| Common Stock Repurchased | -101,000 | -34,000 | N/A | N/A | N/A |
| Other Financing Activity | -8,000 | -6,000 | -4,000 | -2,000 | -7,000 |
| Financing Cash Flow | $-94,000 | $-26,000 | $11,000 | $-3,000 | $-10,000 |
| Exchange Rate Effect | -1,000 | -1,000 | 1,000 | N/A | 5,000 |
| Beginning Cash Position | 858,000 | 858,000 | 858,000 | 858,000 | 1,060,000 |
| End Cash Position | 1,102,000 | 1,005,000 | 1,000,000 | 945,000 | 858,000 |
| Net Cash Flow | $244,000 | $147,000 | $142,000 | $87,000 | $-202,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 353,000 | 186,000 | 160,000 | 89,000 | -193,000 |
| Capital Expenditure | -4,000 | -2,000 | -1,000 | N/A | -4,000 |
| Free Cash Flow | 349,000 | 184,000 | 159,000 | 89,000 | -197,000 |